RECRUITING

Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to see if a Parent Navigator Program (PNP) is helpful for Latino/x parents of babies with congenital heart disease (CHD) to get connected to developmental follow-up services. The main question it aims to answer are: * Do families assigned to the Parent Navigator Program (PNP) have higher rates of connection to High-Risk Infant Follow-Up (HRIF)/Early Intervention (EI) compared to the standard care group 6 months after randomization? * Do children assigned to the Parent Navigator Program (PNP) have better neurodevelopmental outcomes (NDOs) compared to the standard care group 6 months after randomization? * Do parents assigned to the Parent Navigator Program (PNP) have decreased parental stress compared to the standard care group? Researchers will compare the Parent Navigator group to the standard care group to see if parent navigator group is helpful in connecting families to High-Risk Infant Follow-Up (HRIF)/Early Intervention (EI), improving neurodevelopmental outcomes (NDOs), and lowering parental stress. Participants will: * Undergo developmental assessments and survey at newborn stage and at 6 months * Participants randomly assigned to the Parent Navigator group will have weekly (at least) phone calls with the parent navigator * Participants randomly assigned to the Parent Navigator group will complete a 30-minute phone interview about their experience with the parent navigator program 6 months after random assignment

Official Title

Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents

Quick Facts

Study Start:2025-10-01
Study Completion:2026-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07023367

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:0 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Infants born with CHD requiring medical/surgical intervention at less than 30 days of age
  2. * Identify as Latino/x
  1. * Presence of a major genetic syndrome
  2. * Intraventricular hemorrhage or other major structural brain lesion
  3. * Undergoing end of life care

Contacts and Locations

Study Contact

Emma Salmon, BS
CONTACT
323-361-5103
esalmon@chla.usc.edu

Principal Investigator

Nhu Tran, PhD, RN
PRINCIPAL_INVESTIGATOR
Children's Hospital Los Angeles

Study Locations (Sites)

Children's Hospital Los Angeles
Los Angeles, California, 90027
United States

Collaborators and Investigators

Sponsor: Children's Hospital Los Angeles

  • Nhu Tran, PhD, RN, PRINCIPAL_INVESTIGATOR, Children's Hospital Los Angeles

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-10-01
Study Completion Date2026-06-30

Study Record Updates

Study Start Date2025-10-01
Study Completion Date2026-06-30

Terms related to this study

Keywords Provided by Researchers

  • Congenital Heart Disease
  • Parent Navigator Program
  • Latino/x Children
  • High-Risk Infant Follow-up (HRIF)
  • Early Intervention (EI)
  • Neurodevelopmental Outcomes

Additional Relevant MeSH Terms

  • Congenital Heart Disease